首页 | 本学科首页   官方微博 | 高级检索  
     

刺五加注射液中3个主要活性成分与相应单体在大鼠体内的药动学比较
引用本文:范惠霞,邓志鹏,仲浩,徐晓婷,姚庆强. 刺五加注射液中3个主要活性成分与相应单体在大鼠体内的药动学比较[J]. 中国中药杂志, 2014, 39(10): 1921-1927
作者姓名:范惠霞  邓志鹏  仲浩  徐晓婷  姚庆强
作者单位:山东省医学科学院 药物研究所, 山东 济南 250062;济南大学 山东省医学科学院医学与生命科学学院, 山东 济南 250022;山东省罕少见病重点实验室, 山东 济南 250062;山东省医学科学院 药物研究所, 山东 济南 250062;山东省罕少见病重点实验室, 山东 济南 250062;山东省医学科学院 药物研究所, 山东 济南 250062;山东省罕少见病重点实验室, 山东 济南 250062;山东省医学科学院 药物研究所, 山东 济南 250062;济南大学 山东省医学科学院医学与生命科学学院, 山东 济南 250022;山东省罕少见病重点实验室, 山东 济南 250062;山东省医学科学院 药物研究所, 山东 济南 250062;山东省罕少见病重点实验室, 山东 济南 250062
摘    要:研究刺五加注射液中3个活性成分,紫丁香苷、刺五加苷E及异嗪皮啶在大鼠体内的药动学行为,并与相应单体分别经静脉注射给药后大鼠体内药动学行为比较。将24只雄性大鼠随机分为4组,分别经静脉注射给予紫丁香苷、刺五加苷E、异嗪皮啶及相当剂量的刺五加注射液。采用液相色谱-串联四级杆质谱(liquid chromatography tandem mass spectrometry,LC-MS/MS)法测定不同时间点血浆中紫丁香苷、刺五加苷E及异嗪皮啶的浓度并采用DAS 2.0 数据处理软件及SPSS 17.0 统计软件分别进行药动学参数计算及比较。静脉给药后,3种单体成分与刺五加注射液主要药动学参数如血药浓度-时间曲线下面积(AUC)、血浆清除率(CL)、消除半衰期(t1/2)等存在显著性差异(P<0.05)。刺五加注射液中紫丁香苷AUC较单体给药组明显增大,CL较单体给药组明显减小;刺五加苷E的AUC较单体给药组明显减小,CL较单体给药组明显增大;注射液中异嗪皮啶较单体给药组t1/2延长。可见与单体给药相比,刺五加注射液中紫丁香苷、刺五加苷E及异嗪皮啶大鼠体内的代谢动力学过程存在差异。刺五加注射液中的其他共存成分可能对单个有效成分的主要药动学参数产生影响。

关 键 词:紫丁香苷  刺五加苷E  异嗪皮啶  刺五加注射液  药动学比较
收稿时间:2013-12-09

Comparative pharmacokinetics of syringin, eleutheroside E and isofraxidin in rat plasma after intravenous administration of each monomer and Ciwujia injection
FAN Hui-xi,DENG Zhi-peng,ZHONG Hao,XU Xiao-ting and YAO Qing-qiang. Comparative pharmacokinetics of syringin, eleutheroside E and isofraxidin in rat plasma after intravenous administration of each monomer and Ciwujia injection[J]. China Journal of Chinese Materia Medica, 2014, 39(10): 1921-1927
Authors:FAN Hui-xi  DENG Zhi-peng  ZHONG Hao  XU Xiao-ting  YAO Qing-qiang
Affiliation:Institute of Materia Medica, Shandong Academy of Medical Sciences, Ji'nan 250062, China;School of Medinice and Life Sciences, University of Ji'nan and Shandong Academy of Medical Science, Ji'nan 250022, China;Key Laboratory of Rare and Uncommon Diseases of Shandong Province, Ji'nan 250062, China;Institute of Materia Medica, Shandong Academy of Medical Sciences, Ji'nan 250062, China;Key Laboratory of Rare and Uncommon Diseases of Shandong Province, Ji'nan 250062, China;Institute of Materia Medica, Shandong Academy of Medical Sciences, Ji'nan 250062, China;Key Laboratory of Rare and Uncommon Diseases of Shandong Province, Ji'nan 250062, China;Institute of Materia Medica, Shandong Academy of Medical Sciences, Ji'nan 250062, China;School of Medinice and Life Sciences, University of Ji'nan and Shandong Academy of Medical Science, Ji'nan 250022, China;Key Laboratory of Rare and Uncommon Diseases of Shandong Province, Ji'nan 250062, China;Institute of Materia Medica, Shandong Academy of Medical Sciences, Ji'nan 250062, China;Key Laboratory of Rare and Uncommon Diseases of Shandong Province, Ji'nan 250062, China
Abstract:To compare the pharmacokinetics of syringin, eleutheroside E and isofraxidin after intravenous administration of each monomer and Ciwujia injection. Twenty-four Sprague-Dawley rats were randomly divided into four groups and intravenously administrated with syringin, eleutheroside E, isofraxidin, and Ciwujia injection, respectively. The concentrations of the three components in rat plasma were determined by LC-MS/MS. DAS 2.0 software was applied to calculate the pharmacokinetic parameters while the SPSS 17.0 software was used for statistical analysis. Significant difference(P<0.05)was found between each monomer and the injection on the main pharmacokinetic parameters such as AUC, CL and t1/2. Compared with the injection, the group treated with the syringin has obvious decrease in AUC, and increase in CL while the group treated with eleutheroside E has obvious increase in AUC, and decrease in CL. The t1/2 of isofraxidin was prolonged in Ciwujia injection. Pharmacokinetic characters of the ingredients in the injection varied greatly from the monomer. Other constituents in the injection may have an impact on the pharmacokinetic profiles of these three components.
Keywords:syringin  eleutheroside E  isofraxidin  Ciwujia injection  comparative pharmacokinetics
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号